Relative bioavailability comparison of Alprazolam 0.5mg tablet formulations in healthy adult male volunteers under fasting conditions

Raha Pharmaceutical Company0 sites24 target enrollmentStarted: TBDLast updated: February 22, 2021

Trial Snapshot

No summary available.

•Gender: Male
•Age between 18 and 50 years
•The volenteer is willing to do the study and can sign and submit the informed consent form
•The candidate is fully present during the study and according to the consent form, believes in and adheres to the implementation of the study protocol
•Candidate must have a specific place of residence and a landline
•Normal clinical and laboratory results

•History of allergy or allergy to alprazolam
•Any history of hypersensitivity or intolerance that, in the opinion of the researcher, reduces the safety of the study volunteers
•Any history of chronic infectious disease, systemic defects, or organ dysfunction
•Presence of gastrointestinal disease or a history of malabsorption in the last year
•A history of a medical problem over the last year that required medication or hospitalization
•Drugs that significantly induce or inhibit drug-metabolizing enzymes that be used within 30 days prior to administration
•Receive any medication from previous research studies within 30 days prior to the current study
•Donation or loss of significant amounts of blood (480 ml or more) within 30 days prior to current study
•Smokers or addicts

Sponsor

Raha Pharmaceutical Company